Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

22 results
Display

A Case of Recurrent Vogt-Koyanagi-Harada Disease Successfully Treated with Adalimumab in Young Female Adult Patient

Kwon HY, Woo SJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study

Han M, Jung YS, Cheon JH, Park S

PURPOSE: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with ulcerative colitis (UC) are extremely limited, especially in the Asian population. We compared clinically important...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Hidradenitis Suppurativa Patient with Klinefelter Syndrome by Adalimumab

Shin JY, Hong JY, Lee HJ, Sim CY, Park YL, Lee JS, Lee SY, Kim JE

Hidradenitis suppurativa (HS) is a chronic, inflammatory and painful skin disease with recurrent nodules and tracts involving the intertriginous regions. It is known that the patient with HS shows an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pulmonary Extraintestinal Manifestation of Crohn's Disease Treated Successfully with Adalimumab

Shin D, Park BK, Seo J, Won SY, Lee MK, Hong YK, Cho YS

Pulmonary extraintestinal manifestation is rare in Crohn's disease and has been reported in only a few cases. Despite the presence of pulmonary abnormalities in a significant proportion of patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful Treatment of Refractory Cutaneous Polyarteritis Nodosa with Adalimumab

Ahn E, So MW

Cutaneous polyarteritis nodosa (CPAN) is a form of necrotizing vasculitis of the medium and small-sized arteries. The condition is limited to the skin and there is a lack of visceral...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis

Midha V, Mahajan R, Mehta V, Narang V, Singh A, Kaur K, Sood A

BACKGROUND/AIMS: Data on the efficacy and safety of the adalimumab biosimilar Exemptia are limited. METHODS: Patients with moderate-to-severe active steroid-refractory ulcerative colitis (UC) treated at Dayanand Medical College and Hospital, India...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New-onset Psoriasis Induced by Adalimumab Administered for Rheumatoid Arthritis

Suh HY, Kim KH, Ahn JY, Park MY, Youn JI

  • KMID: 2391181
  • Korean J Dermatol.
  • 2017 Aug;55(7):480-482.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Efficacy and Safety of Secukinumab and Adalimumab in Patients with Active Ankylosing Spondylitis: A Bayesian Network Meta-analysis of Randomized Controlled Trials

Lee YH, Song GG

OBJECTIVE: This study assessed the efficacy and safety of secukinumab and adalimumab in patients with active ankylosing spondylitis (AS). METHODS: A Bayesian network meta-analysis was performed with direct and indirect data...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial

Inoue N, Kobayashi , Naganuma M, Hirai F, Ozawa M, Arikan D, Huang B, Robinson A, Thakkar RB, Hibi T

BACKGROUND/AIMS: Intestinal Behçet's disease (BD) is an immune-mediated inflammatory disorder. We followed up the patients and evaluated safety profile and effectiveness of adalimumab for the treatment of intestinal BD through...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Park J, Cheon JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Refractory Oral Aphthous Ulcer Successfully Treated with Adalimumab

Kim J, Song MJ, Jeong HJ, Cho SK, Sung YK

Oral aphthous ulcer is a common lesion characterized by loss of dermal tissue of various shapes in many diseases. It is not serious, but may affect quality of life through...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease

Ji CC, Takano S

BACKGROUND/AIMS: Infliximab has proven to be effective in the treatment of perianal fistulas in Crohn's disease (CD) but the efficacy of adalimumab is still unclear. The aim of this study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?

Im JP

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab Injection

Lee JH, Chang IK, Lee HE, Im M, Seo YJ, Lee JH, Lee Y

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis

Park JW, Seok HY, Kim Y, Kim BJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tuberculosis Cutis Orificialis in Adalimumab Related Immunosupressive Patient

Iskandarli M, Gerceker Turk B, Yaman B, Ceylan N, Ceylan C

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab

Okabayashi S, Kobayashi , Sujino T, Ozaki R, Umeda S, Toyonaga T, Saito E, Nakano M, Tablante M, Morinaga S, Hibi T

Extracolonic involvement of the gastrointestinal tract is extremely uncommon in ulcerative colitis (UC) and rarely found in the upper gastrointestinal tract or in postoperative cases since it typically responds to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study

Lin WC, Chou JW, Yen HH, Hsu WH, Lin HH, Lin JK, Chuang CH, Huang TY, Wang HY, Wei SC, Wong JM

BACKGROUND/AIMS: In Taiwan, due to budget limitations, the National Health Insurance only allows for a limited period of biologics use in treating moderate to severe Crohn's disease (CD). We aimed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis

Seol JE, Park IH, Lee W, Kim H, Jung SY, Wang HY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study

Song WJ, Kang B, Choi SY, Choe YH

PURPOSE: We aimed to investigate the efficacy and safety of adalimumab in pediatric-onset Crohn's disease patients who had failed treatment with infliximab. METHODS: In this retrospective study, patients included were those...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr